High incidence rate of vertebral fractures during chronic prednisone treatment, in spite of bisphosphonate or alfacalcidol use. Extension of the Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis-trial

J. N. Hoes*, J. W. G. Jacobs, H. M. J. Hulsmans, R. N. J. T. L. de Nijs, Willem F. Lems, G. A. W. Bruyn, P. P. M. M. Geusens, Johannes W J Bijlsma

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)354-359
JournalClinical and Experimental Rheumatology
Volume28
Issue number3
Publication statusPublished - 2010

Keywords

  • Glucocorticoid induced osteoporosis
  • bisphosphonate
  • vitamin D
  • alendronate
  • alfacalcidol
  • rheumatic disease
  • vertebral fracture
  • STOP-trial

Cite this